Sapna joined the Board in 2021 and became Deputy Chair in 2024.  She is a member of the Remuneration Committee.

Sapna is a non-executive director of BioPharma Credit PLC, Blackrock Greater Europe Investment Trust and Supermarket Income REIT plc.

Sapna Shah has over 20 years of investment banking experience advising international companies, including listed REITs and investment companies, on mergers and acquisitions, IPOs and equity capital market transactions.  Sapna is a Senior Adviser at Panmure Gordon Limited having previously been Co-Head of the Investment Companies Team.  Prior to this she held senior investment banking roles at UBS AG, Oriel Securities (now Stifel Nicolaus Europe) and Cenkos Securities (now Cavendish Financial).

Until recently, Sapna was a member of the FCA and LSE working groups focusing on the Investment Funds sector.  She has previously served on the advisory committee for a private solar energy company.